NEW YORK (GenomeWeb News) – The Barbara Ann Karmanos Cancer Institute has been granted nearly $4.7 million from the US Army to seek out genetic signatures for cancer diagnostics ostensibly to be used in the care of US military families, the institute said Thursday.
The US Army’s Medical Research and Materiel Command will give the National Oncogenomics and Molecular Imaging Center $2.1 million this week to cover research over the coming year, and it will provide another $2.5 million around the same time next year to fund another 12-month study period.
The funding “provides the underpinning to help us develop a molecular diagnostic method to create specific and personalized cancer treatments,” Karmanos President and CEO John Ruckdeschel said in a statement.
Karmanos’ NOMIC will use the funds to identify oncogenic signatures in individuals, and it will provide imaging technologies to help detect these genes and to measure response to treatment.
The Detroit-based institute said the effort to win the funds was “spearheaded and supported” by Senators Carl Levin (D – Mich.) and Debbie Stabenow (D – Mich.), and by Congressman Joe Knollenberg (R – Mich.).
“It is critical that we unite as a government to support innovative technology, advanced research and exceptional care for the health of our nation," Stabenow said in a statement.